We explore how doctors, psychotherapists and counsellors in the UK react to regulatory transparency, drawing on qualitative research involving 51 semi-structured interviews conducted during 2008-10. We use the concept of ‘reactivity mechanisms’ (Espeland and Sauder, 2007) to explain how regulatory transparency disrupts practices through simplifying and decontextualizing them, altering practitioners’ reflexivity, leading to defensive forms of practice. We make an empirical contribution by exploring the impact of transparency on doctors compared with psychotherapists and counsellors, who represent an extreme case due to their uniquely complex practice, which is particularly affected by this form of regulation. We make a contribution to knowle...
In recent years, European pharmaceutical regulators have increasingly committed to heightening acces...
Over the past 10years, European pharmaceutical regulators (especially the European Medicines Agency ...
Drawing on case studies from the modern era of pharmaceutical regulation in the UK, US and Europe, I...
We explore how doctors, psychotherapists and counsellors in the UK react to regulatory transparency,...
The purpose of this paper is to explore general practitioners' (GPs') and psychiatrists' views and e...
Transparency has risen to prominence in risk regulation leading government authorities in Europe and...
In Europe and North America, there is increasing political pressure being put on health regulatory a...
Pharmaceuticals are not permitted on to the market unless they are granted regulatory approval. The ...
This thesis explores the impact of instrumentalism on the praxis of counselling and psychotherapy in...
Self-regulation constitutes an important aspect of the regulatory and oversight process governing pr...
Health care and other professional services are increasingly pressured to open up to outside scrutin...
The concept of transparency has gained widespread appeal in the European pharmaceutical domain, not ...
The concept of transparency has gained widespread appeal in the European pharmaceutical domain, not ...
Over the past 10 years, European pharmaceutical regulators (especially the European Medicines Agency...
In recent years, European pharmaceutical regulators have increasingly committed to heightening acces...
In recent years, European pharmaceutical regulators have increasingly committed to heightening acces...
Over the past 10years, European pharmaceutical regulators (especially the European Medicines Agency ...
Drawing on case studies from the modern era of pharmaceutical regulation in the UK, US and Europe, I...
We explore how doctors, psychotherapists and counsellors in the UK react to regulatory transparency,...
The purpose of this paper is to explore general practitioners' (GPs') and psychiatrists' views and e...
Transparency has risen to prominence in risk regulation leading government authorities in Europe and...
In Europe and North America, there is increasing political pressure being put on health regulatory a...
Pharmaceuticals are not permitted on to the market unless they are granted regulatory approval. The ...
This thesis explores the impact of instrumentalism on the praxis of counselling and psychotherapy in...
Self-regulation constitutes an important aspect of the regulatory and oversight process governing pr...
Health care and other professional services are increasingly pressured to open up to outside scrutin...
The concept of transparency has gained widespread appeal in the European pharmaceutical domain, not ...
The concept of transparency has gained widespread appeal in the European pharmaceutical domain, not ...
Over the past 10 years, European pharmaceutical regulators (especially the European Medicines Agency...
In recent years, European pharmaceutical regulators have increasingly committed to heightening acces...
In recent years, European pharmaceutical regulators have increasingly committed to heightening acces...
Over the past 10years, European pharmaceutical regulators (especially the European Medicines Agency ...
Drawing on case studies from the modern era of pharmaceutical regulation in the UK, US and Europe, I...